IP Library Granted Patent US 7,563,571
Granted Patent B1
US 7,563,571 · App. 11/187,670 · Granted Jul 21, 2009

MYH gene variants and use thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,563,571
App. No.
11/187,670
Granted
Jul 21, 2009
Kind
B1
Abstract

Variants in MYH gene are disclosed which can result in abnormal synthesis of MYH proteins and alteration of MYH activities. The invention provides methods for detecting the newly discovered genetic variants. Use of MYH genetic variants as biomarkers in diagnosing cancer and detecting a predisposition to cancer are also disclosed herein.

Claims (13)

1. A method for genotyping an individual comprising:

detecting a genetic variant that results in an amino acid variant at position R231H, in reference to SEQ ID NO:2, in the MYH gene of the individual.

2. The method of claim 1 , wherein said detecting step comprises sequencing the MYH gene or a portion thereof.

3. A method as in claim 1 , wherein detecting said genetic variant is indicative of an increased likelihood of cancer.

4. A method as in claim 3 , wherein said cancer is colon cancer.

5. A method comprising:

isolating from an individual a genetic variant that corresponds to an amino acid variant at the position R231H, in reference to SEQ ID NO:2, in the MYH gene of the individual; and

determining the presence of said genetic variant.

6. A method for determining an increased likelihood for developing colon cancer in an individual, comprising:

determining whether the individual has a genetic variant that encodes for an amino acid variant at the position R231H, in reference to SEQ ID NO:2, in the MYH gene of the individual, wherein the presence of said genetic variant is indicative of an increased likelihood for developing colon cancer.

7. The method of claim 5 , wherein said determining step comprises sequencing the MYH gene or a portion thereof.

8. A method as in claim 5 , wherein the presence of said genetic variant is indicative of an increased likelihood of cancer.

9. A method as in claim 8 , wherein said cancer is colon cancer.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jul 10, 2023
From: JPMORGAN CHASE BANK, N.A.
To: MYRIAD GENETICS, INC.; CRESCENDO BIOSCENCE, INC.; MYRIAD RBM, INC.; MYRIAD WOMEN'S HEALTH, INC.
Reel/Frame 064239/0091 →
SECURITY INTEREST Recorded Dec 27, 2016
From: MYRIAD GENETICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 041198/0578 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2005
From: SCHOLL, THOMAS; ELIASON, KRISTILYN; JUDKINS, THADDEUS S.
To: MYRIAD GENETICS, INC.
Reel/Frame 017119/0890 →